Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.

Matthew D HickeyJanet GrochowskiFrancis Mayorga-MunozJon OskarssonElizabeth ImbertMatthew SpinelliJohn D SzumowskiAyesha AppaKimberly KoesterEmily F DauriaMoira McNultyJonathan ColasantiDiane V HavlirMonica GandhiKaterina A Christopoulos

Published in: Journal of acquired immune deficiency syndromes (1999) (2024)

Multi-level strategies to support LA-CAB/RPV implementation for PWH without VS are required, which may necessitate additional resources in some settings to implement safely and effectively. Advocacy to eliminate outer-context barriers, including prior authorizations and specialty pharmacy restrictions, is needed.

Keyphrases

primary care
healthcare
antiretroviral therapy
quality improvement
hiv positive
hiv infected
human immunodeficiency virus
hiv testing
hepatitis c virus
hiv aids
hiv infected patients
men who have sex with men
hyaluronic acid
south africa
medical students